aniHotmail

$OTLK good buy for long term investment

看多
NASDAQ:OTLK   Outlook Therapeutics, Inc.
$OTLK seems to be breaking out upside on the bullish news - reported statistically significant achievement on Phase 3 trial for both Primary and Secondary endpoints!

The chart also shows the double bottom pattern completed with parallel channel formed above it, which is now being broken out upward.

Irregardless where it goes in short term, the company has potential to have 12 years of marketing exclusivity if their BLA get's approved.

Good buy range:
$2.2 - $4

Potential downside - $1.6-$1.8
Price isn't too bad with current estimated global market of $13.1B

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。